for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pfizer Inc.

PFE

Latest Trade

34.39USD

Change

0.19(+0.56%)

Volume

30,589,931

Today's Range

33.95

 - 

34.55

52 Week Range

27.88

 - 

43.08

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
34.20
Open
34.29
Volume
30,589,931
3M AVG Volume
821.29
Today's High
34.55
Today's Low
33.95
52 Week High
43.08
52 Week Low
27.88
Shares Out (MIL)
5,577.63
Market Cap (MIL)
191,814.70
Forward P/E
10.42
Dividend (Yield %)
4.54

Next Event

Pfizer Inc at Barclays Global Healthcare Conference (Virtual)

Latest Developments

More

EMA Says Latest Safety Data For Pfizer's COVID-19 Vaccine In Line With Known Benefit-Risk Profile

U.S. FDA Expands Approval Of Pfizer’S LORBRENA For ALK-Positive Metastatic Lung Cancer

Health Canada Allows More Flexible Storage And Transportation Conditions For Pfizer-Biontech COVID-19 Vaccine

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Pfizer Inc.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Industry

Biotechnology & Drugs

Contact Info

235 E 42ND ST

NEW YORK, NY

10017-5703

United States

+1.212.5732323

https://www.pfizer.com/

Executive Leadership

Albert Bourla

Chairman of the Board, Chief Executive Officer

John D. Young

Chief Business Officer, Group President

Frank A. D'Amelio

Chief Financial Officer, Executive Vice President - Business Operations and Global Supply

Angela Hwang

Group President, Pfizer Biopharmaceuticals Group

Dawn Rogers

Chief Human Resource Officer, Executive Vice President

Key Stats

2.59 mean rating - 22 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

53.6K

2019

51.8K

2020

41.9K

2021(E)

62.0K
EPS (USD)

2018

3.000

2019

2.950

2020

2.220

2021(E)

3.302
Price To Earnings (TTM)
27.54
Price To Sales (TTM)
4.58
Price To Book (MRQ)
3.03
Price To Cash Flow (TTM)
16.26
Total Debt To Equity (MRQ)
62.99
LT Debt To Equity (MRQ)
58.72
Return on Investment (TTM)
5.44
Return on Equity (TTM)
4.36

Latest News

Latest News

U.S. administers 85 million doses of COVID-19 vaccines: CDC

The United States has administered 85,008,094 doses of COVID-19 vaccines as of Friday morning and delivered 114,133,115 doses, the Centers for Disease Control and Prevention said.

BRIEF-Pfizer will move up deliveries of COVID-19 Vaccine to Canada, sending additional 1.5 million doses in March and another 1 million doses in both April and May - Prime Minister Trudeau

* PFIZER WILL MOVE UP DELIVERIES OF COVID-19 VACCINE TO CANADA, SENDING ADDITIONAL 1.5 MILLION DOSES IN MARCH AND ANOTHER 1 MILLION DOSES IN BOTH APRIL AND MAY - PRIME MINISTER TRUDEAU Source text for Eikon: Further company coverage: [ ] (Reporting by David Ljunggren)

Rwanda becomes first African nation to use Pfizer COVID-19 vaccine

Rwanda began its COVID-19 vaccine campaign on Friday, becoming the first nation in Africa to use pharmaceutical company Pfizer's doses that require ultra-cold storage.

Drugmaker Takeda asks Japan for Moderna COVID-19 shot approval

Takeda Pharmaceutical said it had asked regulators to approve use of Moderna's COVID-19 vaccine on Friday, which would add a third option to Japan's vaccination programme.

Japan sees fourfold jump in vaccine procurement in April from March

The minister overseeing Japan's vaccination programme, Taro Kono, said on Friday shipments to Japan of COVID-19 vaccine developed by Pfizer Inc and BioNTech will likely make a nearly fourfold jump in April from the previous month.

S.Africa regulator says at advanced stage of Pfizer vaccine review

South Africa's medicines regulator said on Thursday that it was at an advanced stage of reviewing an emergency use application for Pfizer's COVID-19 vaccine.

South Korea approves Pfizer covid-19 vaccine: drug safety ministry

South Korea's drug safety ministry said on Friday it has granted final approval for the use of Pfizer's coronavirus vaccine.

U.S. administers 82.6 million doses of COVID-19 vaccines: CDC

The United States has administered 82,572,848 doses of COVID-19 vaccines as of Thursday morning and delivered 109,905,530 doses, the Centers for Disease Control and Prevention said.

Pfizer emergency use application in S.Africa in 'advanced stages' - regulator

South Africa's drug regulatory authority SAHPRA told Reuters on Thursday that an emergency use application for Pfizer's COVID-19 vaccine was "in advanced stages of review". (Reporting by Wendell Roelf Editing by Alexander Winning)

BRIEF-EMA Says Latest Safety Data For Pfizer's COVID-19 Vaccine In Line With Known Benefit-Risk Profile

* EMA SAYS LATEST SAFETY DATA FOR PFIZER'S COVID-19 VACCINE ARE IN LINE WITH THE KNOWN BENEFIT-RISK PROFILE

Pfizer/BioNTech, Astrazeneca COVID-19 vaccine data encouraging: WHO

Recent data on COVID-19 vaccinations with the Pfizer/BioNTech and AstraZeneca shots are encouraging, the European regional adviser to the World Health Organization told reporters on Thursday.

Raging pandemic shuts down Sao Paulo as Brazil nears Pfizer deal

Brazil set a daily record for COVID-19 deaths for a second straight day on Wednesday, as a raging resurgence of the virus led Sao Paulo state to shutter businesses and the government to try to close vaccine deals with Pfizer and Janssen.

U.S. administers 80.5 million doses of COVID-19 vaccines: CDC

The United States has administered 80,540,474 doses of COVID-19 vaccines as of Wednesday morning and delivered 107,028,890 doses, the Centers for Disease Control and Prevention said.

Brazil agrees to buy 100 million doses of Pfizer's COVID-19 vaccine -media

The Brazilian government has reached an agreement to buy 100 million doses of Pfizer Inc's COVID-19 vaccine, Globo News cable channel reported on Wednesday.

Czechs and Slovaks to get 100,000 extra vaccines each from EU partners

The Czech Republic and Slovakia, both under severe pressure from the coronavirus pandemic, will each receive an extra 100,000 doses of Pfizer/BioNTech vaccine from their European Union partners.

Kenya hails first vaccine 'bazookas', Rwanda secures Pfizer shots

Kenya received over a million doses of the AstraZeneca COVID-19 vaccine on Wednesday, while Rwanda said it was the first in Africa to secure shots from Pfizer, as efforts to inoculate the world's poorest nations accelerated.

UK data show COVID vaccines work, scientists urge others to take note

British scientists urged European countries to take note on Wednesday of interim data showing what they described as "remarkable" effectiveness of a single dose of Pfizer's or AstraZeneca's COVID-19 vaccines in frail and elderly people.

Austria to get extra vaccines, study South African variant hotspot

Austria will receive an extra 100,000 doses of Pfizer's coronavirus vaccine to administer to all adults in a hotspot of the South African variant and carry out a study there on the drug's efficacy, the government said on Wednesday.

Interim UK study finds one dose of COVID shots reduces hospitalisation

One dose of either Pfizer-BioNTech's or AstraZeneca's COVID-19 vaccine helps to prevent disease severe enough to require hospitalisation of people in their 80s with other illnesses, interim data from a UK study showed on Wednesday.

First Pfizer COVID-19 vaccines to Africa under COVAX go to Rwanda

The first doses of the Pfizer COVID-19 shots to be dispatched to Africa under the global COVAX vaccine-sharing scheme were to arrive in Rwanda on Wednesday, as efforts to inoculate the world's poorest nations accelerate.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up